Mark Hahn
Director of Finance/CFO bij VERONA PHARMA PLC
Vermogen: 129 M $ op 31-03-2024
Profiel
Mark W.
Hahn is an Independent Director at ALSP Orchid Acquisition Corp.
I and the Chief Financial Officer at Verona Pharma Plc.
He was previously the Chief Financial Officer at Charles & Colvard Ltd., Athenix Corp., Gigabeam Corp., BuildLinks, Inc., Cempra Pharmaceuticals, Inc., Cempra, Inc., and Dova Pharmaceuticals, Inc. He was also a Principal at Ernst & Young LLP and the Chief Financial Officer at Equitel, Inc. Hahn received his undergraduate degree from the University of Wisconsin-Milwaukee in 1984.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
VERONA PHARMA PLC
13.38% | 01-02-2024 | 64 268 512 ( 13.38% ) | 129 M $ | 31-03-2024 |
Actieve functies van Mark Hahn
Bedrijven | Functie | Begin |
---|---|---|
VERONA PHARMA PLC | Director of Finance/CFO | 01-03-2020 |
ALSP ORCHID ACQUISITION CORPORATION I | Director/Board Member | 01-11-2021 |
Eerdere bekende functies van Mark Hahn
Bedrijven | Functie | Einde |
---|---|---|
DOVA PHARMACEUTICALS, INC. | Director of Finance/CFO | 12-11-2019 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Director of Finance/CFO | 30-11-2017 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Director of Finance/CFO | 01-11-2017 |
GIGABEAM CORPORATION | Director of Finance/CFO | 31-08-2008 |
Opleiding van Mark Hahn
University of Wisconsin-Milwaukee | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CHARLES & COLVARD, LTD. | Consumer Durables |
VERONA PHARMA PLC | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Equitel, Inc.
Equitel, Inc. Specialty TelecommunicationsCommunications Equitel, Inc. provides prepaid telecommunications services. It provides cellular telephone, prepaid telephony solutions to retailers, distributors, communications service providers, business service providers, and consumers. Equitel was founded in 1999 and is headquartered in Raleigh, NC. | Communications |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Gigabeam Corp.
Gigabeam Corp. Wireless TelecommunicationsCommunications Gigabeam Corp. engages in the provision of fixed wireless communication equipment. It produces, leases, installs and services multi-gigabit wireless communications equipment. The company was founded by Louis S. Slaughter and Douglas G. Lockie on January 5, 2004 and is headquartered in Herndon, VA. | Communications |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
ALSP Orchid Acquisition Corp. I
ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |